Search Results - Stephan Hutter

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    The clinical relevance of sole loss of chromosome Y in myeloid neoplasms by Sandra Huber, Stephan Hutter, Manja Meggendorfer, Christian Pohlkamp, Torsten Haferlach, Isolde Summerer

    Published in Blood Cancer Journal (2026-05-01)
    Get full text
    Article


  2. 2

    “Somatic” and “pathogenic” - is the classification strategy applicable in times of large-scale sequencing? by Constance Baer, Wencke Walter, Stephan Hutter, Sven Twardziok, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach

    Published in Haematologica (2019-08-01)
    Get full text
    Article


  3. 3

    P689: CLASSIFICATION OF MDS AND AML BASED SOLELY ON GENETICS OMITTING BLAST COUNTING – A WAY TO RESOLVE THE DISCREPANCIES BETWEEN CLASSIFICATIONS ACCORDING TO WHO AND ICC? by Claudia Haferlach, Sandra Huber, Constance Baer, Stephan Hutter, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Gregor Hoermann

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  4. 4

    Two ways to complex karyotype in MDS—the role of del(5q) and TP53 by Sandra Huber, Stephan Hutter, Constance Baer, Manja Meggendorfer, Gregor Hoermann, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach

    Published in Blood Cancer Journal (2025-05-01)
    Get full text
    Article


  5. 5

    P694: RISK ASSESSMENT ACCORDING TO IPSS-M IS SUPERIOR TO AML ELN 2022 RISK CLASSIFICATION IN MDS/AML PATIENTS DEFINED BY ICC – IS AN INCLUSION INTO AML TRIALS JUSTIFIED? by Sandra Huber, Constance Baer, Stephan Hutter, Frank Dicker, Manja Meggendorfer, Christian Pohlkamp, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach, Gregor Hoermann

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  6. 6

    P708: HIGH MUTATIONAL CONCORDANCE IN PAIRED BONE MARROW AND PERIPHERAL BLOOD SAMPLES IN PATIENTS WITH CONFIRMED OR SUSPECTED MYELODYSPLASTIC NEOPLASM by Natalie Wossidlo, Sandra Huber, Torsten Haferlach, Manja Meggendorfer, Stephan Hutter, Gregor Hoermann, Isolde Summerer, Henning Ruge, Constance Baer, Wolfgang Kern, Claudia Haferlach

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  7. 7

    Interface-guided phenotyping of coding variants in the transcription factor RUNX1 by Kivilcim Ozturk, Rebecca Panwala, Jeanna Sheen, Kyle Ford, Nathan Jayne, Andrew Portell, Dong-Er Zhang, Stephan Hutter, Torsten Haferlach, Trey Ideker, Prashant Mali, Hannah Carter

    Published in Cell Reports (2024-07-01)
    Get full text
    Article


  8. 8

    Myeloid neoplasms with MYC-positive double minutes: towards recognition as a distinct entity by Isolde Summerer, Wencke Walter, Manja Meggendorfer, Torsten Haferlach, Frank Dicker, Stephan Hutter, Niroshan Nadarajah, Anna Stengel, Constanze Kuehn, Wolfgang Kern, John M. Bennett, Claudia Haferlach, Christian Pohlkamp

    Published in Blood Cancer Journal (2025-03-01)
    Get full text
    Article


  9. 9

    P814: ANALYSIS OF TP53 ALTERATIONS BY WGS REVEALS BIALLELIC 17P DELETIONS IN MULTIPLE MYELOMA by Marietta Truger, Stephan Hutter, Wencke Walter, Xiang Zhou, Christine Riedhammer, Manja Meggendorfer, Heiko Müller, Wolfgang Kern, Torsten Haferlach, Hermann Einsele, K Martin Kortum, Claudia Haferlach, Leo Rasche

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  10. 10

    Proximally biased V(D)J recombination in the clonal evolution of IGH alleles in KMT2A::AFF1 BCP‐ALL of all age classes by Heiko Müller, Frank Dicker, Constance Bär, Wencke Walter, Stephan Hutter, Niroshan Nadarajah, Manja Meggendorfer, Qingsong Gao, Ilaria Iacobucci, Charles G. Mullighan, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach

    Published in HemaSphere (2024-04-01)
    Get full text
    Article


  11. 11

    A high proportion of germline variants in pediatric chronic myeloid leukemia by Manuela Krumbholz, Anna Dolnik, Eric Sträng, Tabita Ghete, Sabrina Skambraks, Stephan Hutter, Alfred Simonis, Frank Stegelmann, Meinolf Suttorp, Anselm H.C. Horn, Heinrich Sticht, Torsten Haferlach, Lars Bullinger, Markus Metzler

    Published in Molecular Cancer (2024-09-01)
    Get full text
    Article


  12. 12

    Analysis of 3760 hematologic malignancies reveals rare transcriptomic aberrations of driver genes by Xueqi Cao, Sandra Huber, Ata Jadid Ahari, Franziska R. Traube, Marc Seifert, Christopher C. Oakes, Polina Secheyko, Sergey Vilov, Ines F. Scheller, Nils Wagner, Vicente A. Yépez, Piers Blombery, Torsten Haferlach, Matthias Heinig, Leonhard Wachutka, Stephan Hutter, Julien Gagneur

    Published in Genome Medicine (2024-05-01)
    Get full text
    Article


  13. 13

    Circulating microbial content in myeloid malignancy patients is associated with disease subtypes and patient outcomes by Jakob Woerner, Yidi Huang, Stephan Hutter, Carmelo Gurnari, Jesús María Hernández Sánchez, Janet Wang, Yimin Huang, Daniel Schnabel, Michael Aaby, Wanying Xu, Vedant Thorat, Dongxu Jiang, Babal K. Jha, Mehmet Koyuturk, Jaroslaw P. Maciejewski, Torsten Haferlach, Thomas LaFramboise

    Published in Nature Communications (2022-02-01)
    Get full text
    Article


  14. 14

    IntegrateALL: An end‐to‐end RNA‐seq analysis pipeline for multilevel data extraction and interpretable subtype classification in B‐precursor ALL by Nadine Wolgast, Thomas Beder, Mayukh Mondal, Wencke Walter, Stephan Hutter, Sonja Bendig, Jan Kässens, Björn‐Thore Hansen, Katharina Iben, Sebastian Wolf, Anjali Cremer, Malwine Barz, Martin Neumann, Nicola Gökbuget, Claudia Haferlach, Monika Brüggemann, Claudia D. Baldus, Alina M. Hartmann, Lorenz Bastian

    Published in HemaSphere (2026-04-01)
    Get full text
    Article


  15. 15

    Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q by Vera Adema, Laura Palomo, Wencke Walter, Mar Mallo, Stephan Hutter, Thomas La Framboise, Leonor Arenillas, Manja Meggendorfer, Tomas Radivoyevitch, Blanca Xicoy, Andrea Pellagatti, Claudia Haferlach, Jacqueline Boultwood, Wolfgang Kern, Valeria Visconte, Mikkael Sekeres, John Barnard, Torsten Haferlach, Francesc Solé, Jaroslaw P. Maciejewski

    Published in EBioMedicine (2022-06-01)
    Get full text
    Article


Search Tools: